OBJECTIVES: To evaluate the outcome of treatment for deep sternal wound infection (DSWI) in a nationwide patient cohort, before and after the introduction of negative-pressure wound therapy (NPWT). METHODS: This was a population-based cohort of all patients treated for DSWI in Iceland out of 2446 open heart operations performed between 2000 and 2010. Length of hospital stay, survival and reoperations were compared in (i) 23 patients treated with open and/or closed irrigation before August 2005 (conventional treatment, CvT group) and in (ii) 20 patients treated after this time with NPWT as a first-line therapy (NPWT group). RESULTS: The DSWI rate was 1.8% and did not change during the study period. Demographics were similar for both groups, except for peripheral arterial disease which was less common in the NPWT group. Coagulase-negative staphylococci were also more common (as the only pathogen identified) in the NPWT group (70% vs 30%, P = 0.01). The median length of hospital stay was 43 days in both groups and the sternum could be closed with delayed primary closure in all except 2 patients, one in each group. Eight patients in the CvT group required surgical revision for re-infections, including debridement and rewiring, when compared with 1 patient in the NPWT group (P = 0.02). Furthermore, 6 patients in the CvT group developed late chronic infections of the sternum requiring surgical revision, compared with one in the NPWT group (P = 0.10). The 30-day mortality was not significantly different between groups (4% vs 0%, P > 0.1) and the same was true for 1-year mortality (17% vs 0%, P = 0.11). CONCLUSIONS: NPWT significantly reduces the risk of early re-infections in patients with DSWI. There was a lower rate of late chronic sternal infections and lower mortality in the NPWT group, but the difference was not statistically significant. We conclude that NPWT should be considered as a first-line treatment for most DSWIs.
OBJECTIVES: To evaluate the outcome of treatment for deep sternal wound infection (DSWI) in a nationwide patient cohort, before and after the introduction of negative-pressure wound therapy (NPWT). METHODS: This was a population-based cohort of all patients treated for DSWI in Iceland out of 2446 open heart operations performed between 2000 and 2010. Length of hospital stay, survival and reoperations were compared in (i) 23 patients treated with open and/or closed irrigation before August 2005 (conventional treatment, CvT group) and in (ii) 20 patients treated after this time with NPWT as a first-line therapy (NPWT group). RESULTS: The DSWI rate was 1.8% and did not change during the study period. Demographics were similar for both groups, except for peripheral arterial disease which was less common in the NPWT group. Coagulase-negative staphylococci were also more common (as the only pathogen identified) in the NPWT group (70% vs 30%, P = 0.01). The median length of hospital stay was 43 days in both groups and the sternum could be closed with delayed primary closure in all except 2 patients, one in each group. Eight patients in the CvT group required surgical revision for re-infections, including debridement and rewiring, when compared with 1 patient in the NPWT group (P = 0.02). Furthermore, 6 patients in the CvT group developed late chronic infections of the sternum requiring surgical revision, compared with one in the NPWT group (P = 0.10). The 30-day mortality was not significantly different between groups (4% vs 0%, P > 0.1) and the same was true for 1-year mortality (17% vs 0%, P = 0.11). CONCLUSIONS: NPWT significantly reduces the risk of early re-infections in patients with DSWI. There was a lower rate of late chronic sternal infections and lower mortality in the NPWT group, but the difference was not statistically significant. We conclude that NPWT should be considered as a first-line treatment for most DSWIs.
Authors: Johan Sjögren; Johan Nilsson; Ronny Gustafsson; Malin Malmsjö; Richard Ingemansson Journal: Ann Thorac Surg Date: 2005-10 Impact factor: 4.330
Authors: Johan Sjögren; Ronny Gustafsson; Johan Nilsson; Malin Malmsjö; Richard Ingemansson Journal: Ann Thorac Surg Date: 2005-06 Impact factor: 4.330
Authors: Steinn Steingrimsson; Magnus Gottfredsson; Karl G Kristinsson; Tomas Gudbjartsson Journal: Scand Cardiovasc J Date: 2008-06 Impact factor: 1.589
Authors: Patrick W Domkowski; Monica L Smith; Denis L Gonyon; Carol Drye; Mary Kay Wooten; L Scott Levin; Walter G Wolfe Journal: J Thorac Cardiovasc Surg Date: 2003-08 Impact factor: 5.209
Authors: Aryan S P Patmo; Pieta Krijnen; Wim E Tuinebreijer; Roelf S Breederveld Journal: Adv Wound Care (New Rochelle) Date: 2014-05-01 Impact factor: 4.730
Authors: Shadi Lalezari; Christine J Lee; Anna A Borovikova; Derek A Banyard; Keyianoosh Z Paydar; Garrett A Wirth; Alan D Widgerow Journal: Int Wound J Date: 2016-09-29 Impact factor: 3.315
Authors: Matthew E Falagas; Giannoula S Tansarli; Anastasios Kapaskelis; Konstantinos Z Vardakas Journal: PLoS One Date: 2013-05-31 Impact factor: 3.240